Oral Ascorbic Acid in Combination with Beta-Blockers Is More Effective than Beta-Blockers Alone in the Prevention of Atrial Fibrillation after Coronary Artery Bypass Grafting

Because adrenergic beta antagonists are not sufficient to prevent atrial fibrillation after coronary artery bypass grafting, this prospective, randomized trial was designed to evaluate the effects of ascorbic acid as an adjunct to β-blockers. Fifty patients formed our ascorbic acid group, and anothe...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Eslami, Masoud, Badkoubeh, Roya Sattarzadeh, Mousavi, Mehdi, Radmehr, Hassan, Salehi, Mehrdad, Tavakoli, Nafiseh, Avadi, Mohamad Reza
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2007
Gaiak:
Clinical Investigation
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1995047/
https://ncbi.nlm.nih.gov/pubmed/17948074
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak